Clinical Trial Update: An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. [Phase 4]

View source ↗

Summary

An open, randomized Phase 4 pilot trial evaluated using Basiliximab with optimized cyclosporine dosing in patients undergoing de novo liver transplantation. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Simulect (Basiliximab)

Snippet

Sponsor: Novartis | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED